Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Hepatitis C virus (HCV) E2 glycoprotein is a major envelope protein found on the surface of HCV particles. It plays a central role in viral entry into host cells by interacting with cellular receptors such as CD81. E2 forms a heterodimer with E1, essential for viral attachment and membrane fusion. It is a primary target for neutralizing antibodies, making it a key focus for vaccine and therapeutic development. The protein exhibits high flexibility and intrinsic disorder, conserved across different HCV strains, posing challenges for targeted therapies.
Neutralization of viral entry by blocking receptor binding or fusion.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatitis C virus Envelope Glycoprotein E2.